Effects of long-term intrarenal angiotensin II infusion on renal vascular responsiveness to vasoactive agents

Clin Exp Pharmacol Physiol. 1998 Jul-Aug;25(7-8):633-6. doi: 10.1111/j.1440-1681.1998.tb02267.x.

Abstract

1. We tested whether chronic intrarenal angiotensin II (AngII) infusion altered renal vascular responsiveness to vasoactive agents, which would provide evidence of vascular structural changes. 2. The renal blood flow (RBF) responses to renal arterial administration of bolus doses of acetylcholine, glyceryl trinitrate, AngII and noradrenaline were measured before commencement of and 1 day after cessation of 28 days intrarenal AngII infusion (0.5 ng/kg per min) in chronically instrumented conscious dogs. 3. The RBF responses to these vasoactive agents were unaltered by chronic intrarenal AngII infusion in conscious dogs. 4. These functional studies provide no evidence for renal vascular hypertrophy in response to chronic intrarenal AngII infusion in conscious dogs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Angiotensin II / administration & dosage
  • Angiotensin II / pharmacology*
  • Animals
  • Blood Pressure / drug effects
  • Dogs
  • Injections
  • Kidney
  • Nitroglycerin / pharmacology
  • Norepinephrine / pharmacology
  • Renal Circulation / drug effects*
  • Vascular Resistance / drug effects
  • Vasoconstrictor Agents / pharmacology*
  • Vasodilator Agents / pharmacology*

Substances

  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Angiotensin II
  • Nitroglycerin
  • Acetylcholine
  • Norepinephrine